Variables

Frequency

Percent

Gender

 

 

Male

20

66.7

Female

10

33.3

Type of tumor

 

 

AML

4

13.3

ALL

9

30.0

Ca.breast

2

6.7

Burkitt's lymphoma

2

6.7

Colorectal carcinoma

1

3.3

HL

3

10.0

NHL

4

13.3

Wilm's tumor

1

3.3

Neuroblastoma

1

3.3

PNET

2

6.7

Osteosarcoma

1

3.3

Drug groups

 

 

Adriamycine ,Bleomycin, Decarbazine, Vinblastin

1

3.3

Etoposide, Ifosfamide, Mesna

4

13.3

Daunorubicin, Cytosar

4

13.3

Methotrexate, Vincristion, Adriamycine

1

3.3

Daunorubicin, Methotrexate, Cychlophosphamide, Cytosar

2

6.7

Methotrexate, Cytosar, L-asparginase

1

3.3

Etoposide, Ifosfamide, Decarbazine, Doxorubicine

1

3.3

Daunorubicin, Cytosar, Vincristin, L-asparginase

4

13.3

Bleomycin, Decarbazine, Vinblastin

1

3.3

Vincristin ,Cychlophosphamide, Doxorubicine

2

6.7

Adriamycine ,Bleomycin, Decarbazine, Vincristin

1

3.3

Daunorubicin, Vincristin, L-asparginase, Pridinisolone

2

6.7

Methotrexate ,Cychlophosphamide, 5-fluruouracil

2

6.7

5-fluruouracil, Oxaloplatin, Avastin

1

3.3

Methotrexate, Vincristin, Cychlophosphamide, Adriamycine

1

3.3

Cytosar, Vincristin, L-asparginase, Cychlophosphamide

1

3.3

Vincristin, L-asparginase, Cychlophosphamide, Predinisolone

1

3.3

Total

30

100

Table 9: Patient characteristics, type of tumor and drug groups.